We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Potential Persistent Tuberculosis Treatment

News   Nov 23, 2015

 
Potential Persistent Tuberculosis Treatment
 
 
Advertisement
 

RELATED ARTICLES

Potential New Treatment Tactic for Acute Myeloid Leukemia

News

Researchers demonstrate that factors produced by bone marrow support cells allow leukemia cells to survive treatment with quizartinib. When quizartinib was combined with another tyrosine kinase inhibitor called dasatinib the alternative survival pathways were shut down, leading to more effective leukemia cell death.

READ MORE

Diabetes Drug Candidate Shows Promise in Cell and Mouse Models

News

A new drug candidate SRI-37330 was tested on isolated human and mouse pancreatic islets, mouse and rat cell cultures and animal models of both Type 1 and Type 2 diabetes, and was shown to significantly improve four detrimental characteristics of diabetes.

READ MORE

Team Identifies 21 Existing Drugs That Stop Replication of SARS-CoV-2

News

Researchers have analyzed one of the world’s largest collections of known drugs for their ability to block the replication of SARS-CoV-2, and reported 100 molecules with confirmed antiviral activity. Of these, 21 drugs were found to be effective at concentrations that could be safely administered to patients.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE